Oral contraception with trimegestone

Details Oral contraception with trimegestone Oral contraception with trimegestone

A - Human Necessities

61

K

A61K 31/575 (2006.01) A61K 31/565 (2006.01) A61P 15/18 (2006.01)

Patent

CA 2615427

The invention relates to a method for contraception comprising the administration of trimegestone in combination with ethinyloestradiol to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, wherein on at least one of the at least 21 successive days the daily dose of trimegestone is more than 500 ~g.

L'invention concerne une méthode de contraception comprenant l'administration de trimégestone combinée à de l'éthinyloestradiol à une femme en âge de procréer pendant au moins 21 jours successifs, en commençant le premier jour du cycle menstruel. Au moins l'un des au moins 21 jours successifs, la dose quotidienne de trimégestone est supérieure à 500 ?g.

Affiliated with

Also associated with

Rating

Oral contraception with trimegestone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral contraception with trimegestone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral contraception with trimegestone will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1663834